Volume 20 No 8 (2022)
Download PDF
Evaluation of the Hematological Profile Levels in Iraqi Patients with Multiple Sclerosis
Sarah Abdulhameed Sahib, Ghassan Mohammad Sulaiman , Huda Jaber Waheed
Abstract
Multiple Sclerosis (MS) is a persistent progressive neurological disease of the central nervous system
that attacks the myelinated axons. Discontinuous immune–moderate inflammatory alterations in the
myelin sheath. The MS research community is very interested in characterizing the physiological
variations seen in MS and its subtype, and some studies have shown the presence of cerebrospinal fluid
and hematology-related biomarkers connected to multiple sclerosisstatus. The aim of the study detects
the changing that happened in CBC tests in multiple sclerosis patients.
MS patients (n=100) were divided into two groups; newly diagnosed (42), and patients with ongoing
treatments (58). These groups were compared to healthy subjects (n=55); the mean age ±SD was
(30±8.46 years), (37±8.06years), and (31±8.73 years) for MS newly patients, patients with ongoing
treatments, and healthy subjects, respectively.hematological parameters (hemoglobin concentration
(HB), packed cell volume (PCV), white blood cells (WBC), and platelet count (PLT) were evaluated by
immediately analyzing entire blood for a complete blood picture using the fully automated analyzer
Sysmex Xn 1000 hematology in Baghdad teaching hospital. the result of the current study was the
hematological parameters did not differ significantly [Hb, PCV, WBC, and PLT] in MS patients group
when compared to the control group.
Keywords
multiple sclerosis, Hematology, CBC
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.